Nissay Asset Management Corp Johnson & Johnson Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Nissay Asset Management Corp holds 308,271 shares of JNJ stock, worth $45 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

308,271

Previous 307,830 0.14%

Holding current value

$45 Million

Previous $45 Million 11.04%

% of portfolio

0.32%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $64,156 - $73,814	441 Added 0.14%	308,271 $50 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $3.93 Million - $4.3 Million	-27,238 Reduced 8.13%	307,830 $45 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $201,786 - $211,562	-1,300 Reduced 0.39%	335,068 $53 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $130,312 - $142,197	895 Added 0.27%	336,368 $52.7 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $3.69 Million - $4.13 Million	-23,696 Reduced 6.6%	335,473 $52.2 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $1.84 Million - $1.98 Million	11,927 Added 3.43%	359,169 $59.4 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $44.2 Million - $52.8 Million	-292,735 Reduced 45.74%	347,242 $53.8 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $18.7 Million - $20.9 Million	116,522 Added 22.26%	639,977 $113 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $17.2 Million - $19.1 Million	106,319 Added 25.49%	523,455 $85.5 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $1.08 Million - $1.2 Million	6,438 Added 1.57%	417,136 $74 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $10.2 Million - $11.6 Million	64,675 Added 18.69%	410,698 $72.8 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $2.59 Million - $2.87 Million	16,587 Added 5.03%	346,023 $59.2 Million
Q3 2021 Nov 10, 2021	BUY	$161.5 - $179.47 $1.27 Million - $1.41 Million	7,869 Added 2.45%	329,436 $53.2 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $3.27 Million - $3.5 Million	20,483 Added 6.8%	321,567 $53 Million
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $6.02 Million - $6.7 Million	-39,301 Reduced 11.55%	301,084 $49.5 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $7.44 Million - $8.54 Million	-54,251 Reduced 13.75%	340,385 $53.6 Million
Q3 2020 Oct 20, 2020	SELL	$140.38 - $153.83 $7.36 Million - $8.07 Million	-52,447 Reduced 11.73%	394,636 $58.8 Million
Q2 2020 Jul 27, 2020	BUY	$128.81 - $155.51 $8.78 Million - $10.6 Million	68,190 Added 18.0%	447,083 $62.9 Million
Q1 2020 May 05, 2020	BUY	$111.14 - $153.99 $1.05 Million - $1.46 Million	9,485 Added 2.57%	378,893 $49.7 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.36 Million - $1.56 Million	-10,663 Reduced 2.81%	369,408 $53.9 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $1.02 Million - $1.14 Million	-8,038 Reduced 2.07%	380,071 $49.2 Million
Q2 2019 Aug 07, 2019	BUY	$131.15 - $144.24 $269,644 - $296,557	2,056 Added 0.53%	388,109 $54.1 Million
Q1 2019 May 03, 2019	SELL	$125.72 - $139.79 $1.7 Million - $1.88 Million	-13,483 Reduced 3.37%	386,053 $54 Million
Q4 2018 Feb 06, 2019	BUY	$122.84 - $147.84 $1.6 Million - $1.93 Million	13,043 Added 3.37%	399,536 $51.6 Million
Q3 2018 Oct 30, 2018	SELL	$121.58 - $142.88 $865,892 - $1.02 Million	-7,122 Reduced 1.81%	386,493 $53.4 Million
Q2 2018 Aug 08, 2018	BUY	$119.4 - $131.76 $1.31 Million - $1.45 Million	11,004 Added 2.88%	393,615 $47.8 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $609,612 - $721,886	-4,873 Reduced 1.26%	382,611 $49 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $50.8 Million - $55.7 Million	387,484	387,484 $54.1 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Johnson & Johnson Transaction History